Simona AG SIMONA ORD SHS/ DE000A3E5CP0 /
- - | Chg. - | Volume | Bid06:00:05 | Ask06:00:05 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 378 mill.EUR | 2.70% | 9.71 |
GlobeNewswire
24/06
Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results ...
GlobeNewswire
14/05
Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update
GlobeNewswire
07/05
Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and ...
GlobeNewswire
02/05
Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network
GlobeNewswire
30/04
Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 F...
GlobeNewswire
23/04
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contrace...
GlobeNewswire
11/04
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire
28/03
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
GlobeNewswire
21/03
Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webc...
GlobeNewswire
23/02
Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging
GlobeNewswire
22/02
Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISS...
GlobeNewswire
31/01
Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cre...